---
title: "Layer-Specific Fine-Tuning for Improved Negation Handling in Medical Vision-Lang"
date: 2026-02-16
arxiv: "2602.12498v1"
category: "cs.CV"
model: "google/gemma-3-4b-it:free"
---

# Layer-Specific Fine-Tuning for Improved Negation Handling in Medical Vision-Language Models

## ğŸ“– ë…¼ë¬¸ ì •ë³´

| í•­ëª© | ë‚´ìš© |
|------|------|
| **ì €ì** | Ali Abbasi, Mehdi Taghipour, Rahmatollah Beheshti |
| **ë°œí‘œì¼** | 2026-02-13 |
| **arXiv** | [2602.12498v1](https://arxiv.org/pdf/2602.12498v1) |
| **ì¹´í…Œê³ ë¦¬** | cs.CV |

---

## ğŸ“ ì´ˆë¡ (Abstract)

Negation is a fundamental linguistic operation in clinical reporting, yet vision-language models (VLMs) frequently fail to distinguish affirmative from negated medical statements. To systematically characterize this limitation, we introduce a radiology-specific diagnostic benchmark that evaluates polarity sensitivity under controlled clinical conditions, revealing that common medical VLMs consistently confuse negated and non-negated findings. To enable learning beyond simple condition absence, we further construct a contextual clinical negation dataset that encodes structured claims and supports attribute-level negations involving location and severity. Building on these resources, we propose Negation-Aware Selective Training (NAST), an interpretability-guided adaptation method that uses causal tracing effects (CTEs) to modulate layer-wise gradient updates during fine-tuning. Rather than applying uniform learning rates, NAST scales each layer's update according to its causal contribution to negation processing, transforming mechanistic interpretability signals into a principled optimization rule. Experiments demonstrate improved discrimination of affirmative and negated clinical statements without degrading general vision-language alignment, highlighting the value of causal interpretability for targeted model adaptation in safety-critical medical settings. Code and resources are available at https://github.com/healthylaife/NAST.

---

## ğŸ” AI ë¶„ì„

## ë…¼ë¬¸ ë¶„ì„: Layer-Specific Fine-Tuning for Improved Negation Handling in Medical Vision-Language Models

### ğŸ“„ ë…¼ë¬¸ ìš”ì•½
ë³¸ ë…¼ë¬¸ì€ ì˜ë£Œ ë¶„ì•¼ì˜ ë¹„ì „-ì–¸ì–´ ëª¨ë¸(VLM)ì´ ë¶€ì •ì–´ ë¬¸ì¥ì„ ì œëŒ€ë¡œ ì´í•´í•˜ì§€ ëª»í•˜ëŠ” ë¬¸ì œë¥¼ í•´ê²°í•˜ê¸° ìœ„í•´ ì œì‹œëœ ì—°êµ¬ì…ë‹ˆë‹¤. ì €ìë“¤ì€ ì˜ë£Œ ì§„ë‹¨ ë²¤ì¹˜ë§ˆí¬ì™€ ë¶€ì •ì–´ ë¬¸ì¥ì„ í¬í•¨í•˜ëŠ” êµ¬ì¡°í™”ëœ ë°ì´í„°ì…‹ì„ êµ¬ì¶•í•˜ê³ , í•´ì„ ê°€ëŠ¥ì„±ì„ í™œìš©í•œ â€˜Negation-Aware Selective Training (NAST)â€™ ë°©ë²•ì„ ì œì•ˆí–ˆìŠµë‹ˆë‹¤. NASTëŠ” ê° ë ˆì´ì–´ì˜ ì¤‘ìš”ë„ë¥¼ ë¶„ì„í•˜ì—¬ í•™ìŠµë¥ ì„ ì¡°ì •í•¨ìœ¼ë¡œì¨ ë¶€ì •ì–´ ì²˜ë¦¬ ëŠ¥ë ¥ì„ í–¥ìƒì‹œí‚¤ë©´ì„œ, ì¼ë°˜ì ì¸ ë¹„ì „-ì–¸ì–´ ì •ë ¬ ì„±ëŠ¥ì„ ì €í•˜ì‹œí‚¤ì§€ ì•ŠìŠµë‹ˆë‹¤. ì‹¤í—˜ ê²°ê³¼, NASTë¥¼ í†µí•´ ë¶€ì •ì–´ ë¬¸ì¥ì„ ì •í™•í•˜ê²Œ êµ¬ë¶„í•˜ëŠ” ì„±ëŠ¥ì„ ê°œì„ í–ˆìœ¼ë©°, ì•ˆì „ì´ ì¤‘ìš”í•œ ì˜ë£Œ ë¶„ì•¼ì— ì ìš© ê°€ëŠ¥ì„±ì„ ë³´ì—¬ì¤ë‹ˆë‹¤.

### ğŸ†• ìƒˆë¡œìš´ ì  (Novelty)
ë³¸ ë…¼ë¬¸ì˜ í•µì‹¬ì ì¸ ìƒˆë¡œìš´ ì ì€ ë‹¤ìŒê³¼ ê°™ìŠµë‹ˆë‹¤.

*   **ë ˆì´ì–´ë³„ í•™ìŠµë¥  ì¡°ì •:** ê¸°ì¡´ì˜ ê· ì¼í•œ í•™ìŠµë¥  ì ìš© ë°©ì‹ì—ì„œ ë²—ì–´ë‚˜, ê° ë ˆì´ì–´ì˜ ë¶€ì •ì–´ ì²˜ë¦¬ ê¸°ì—¬ë„ë¥¼ ë¶„ì„í•˜ì—¬ í•™ìŠµë¥ ì„ ê°œë³„ì ìœ¼ë¡œ ì¡°ì •í•˜ëŠ” â€˜NASTâ€™ ë°©ë²•ë¡ ì„ ì œì‹œí–ˆìŠµë‹ˆë‹¤. ì´ëŠ” ê° ë ˆì´ì–´ê°€ ë¶€ì •ì–´ ì²˜ë¦¬ ê³¼ì •ì—ì„œ ê°–ëŠ” ì—­í• ì„ ëª…í™•íˆ íŒŒì•…í•˜ê³ , ìµœì í™”ì— ì§‘ì¤‘í•  ìˆ˜ ìˆë„ë¡ í•©ë‹ˆë‹¤.
*   **í•´ì„ ê°€ëŠ¥ì„± ê¸°ë°˜ ìµœì í™”:**  â€˜Causal Tracing Effects (CTEs)â€™ë¥¼ í™œìš©í•˜ì—¬ ê° ë ˆì´ì–´ì˜ ë¶€ì •ì–´ ì²˜ë¦¬ ê¸°ì—¬ë„ë¥¼ ì¸¡ì •í•˜ê³ , ì´ë¥¼ ê¸°ë°˜ìœ¼ë¡œ í•™ìŠµë¥ ì„ ì¡°ì •í•˜ëŠ” ë°©ì‹ì„ ë„ì…í–ˆìŠµë‹ˆë‹¤. ì´ëŠ” ë‹¨ìˆœí•œ ì„±ëŠ¥ í–¥ìƒì„ ë„˜ì–´, ëª¨ë¸ì˜ ì‘ë™ ë°©ì‹ì„ ì´í•´í•˜ê³  ê°œì„ í•˜ëŠ” ë° ê¸°ì—¬í•©ë‹ˆë‹¤.
*   **ì˜ë£Œ ë¶„ì•¼ íŠ¹í™” ë²¤ì¹˜ë§ˆí¬ ë° ë°ì´í„°ì…‹:** ë¶€ì •ì–´ ë¬¸ì¥ì˜ ì–´ë ¤ì›€ì„ ì²´ê³„ì ìœ¼ë¡œ í‰ê°€í•  ìˆ˜ ìˆëŠ” ì˜ë£Œ ì§„ë‹¨ ë²¤ì¹˜ë§ˆí¬ì™€ êµ¬ì¡°í™”ëœ ë¶€ì •ì–´ ë¬¸ì¥ ë°ì´í„°ì…‹ì„ êµ¬ì¶•í•˜ì—¬, VLMì˜ í•œê³„ë¥¼ ëª…í™•íˆ ë“œëŸ¬ëƒˆìŠµë‹ˆë‹¤.

### ğŸ’ª ê°•ì  (Strengths)
*   **êµ¬ì²´ì ì¸ ë¬¸ì œ í•´ê²°:** ì˜ë£Œ ë¶„ì•¼ VLMì˜ ì¤‘ìš”í•œ í•œê³„ì¸ ë¶€ì •ì–´ ì²˜ë¦¬ ë¬¸ì œë¥¼ ëª…í™•í•˜ê²Œ ì •ì˜í•˜ê³ , ì´ë¥¼ í•´ê²°í•˜ê¸° ìœ„í•œ êµ¬ì²´ì ì¸ ë°©ë²•ì„ ì œì‹œí–ˆìŠµë‹ˆë‹¤.
*   **í•´ì„ ê°€ëŠ¥ì„± ê°•ì¡°:**  CTEsë¥¼ í™œìš©í•˜ì—¬ ëª¨ë¸ì˜ ì‘ë™ ë°©ì‹ì„ ì´í•´í•˜ê³ , ì´ë¥¼ ê¸°ë°˜ìœ¼ë¡œ ìµœì í™”ë¥¼ ìˆ˜í–‰í•¨ìœ¼ë¡œì¨, ëª¨ë¸ì˜ ì‹ ë¢°ì„±ì„ ë†’ì˜€ìŠµë‹ˆë‹¤.
*   **ì‹¤í—˜ì  ê²€ì¦:**  êµ¬ì¶•ëœ ë²¤ì¹˜ë§ˆí¬ì™€ ë°ì´í„°ì…‹ì„ í™œìš©í•˜ì—¬ NAST ë°©ë²•ë¡ ì˜ íš¨ê³¼ë¥¼ ì‹¤í—˜ì ìœ¼ë¡œ ê²€ì¦í•˜ê³ , ì„±ëŠ¥ í–¥ìƒì„ ì…ì¦í–ˆìŠµë‹ˆë‹¤.

### âš ï¸ ì•½ì /í•œê³„ì  (Limitations)
*   **ì˜ë£Œ ë¶„ì•¼ íŠ¹í™”:** ì—°êµ¬ê°€ ì˜ë£Œ ë¶„ì•¼ì— íŠ¹í™”ë˜ì–´ ìˆì–´, ë‹¤ë¥¸ ë¶„ì•¼ì— ì ìš© ê°€ëŠ¥ì„±ì´ ì œí•œì ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.
*   **ë°ì´í„°ì…‹ ê·œëª¨:** êµ¬ì¶•ëœ ë¶€ì •ì–´ ë¬¸ì¥ ë°ì´í„°ì…‹ì˜ ê·œëª¨ê°€ ì œí•œì ì¼ ìˆ˜ ìˆìœ¼ë©°, ë” ë§ì€ ë°ì´í„°ë¥¼ í™•ë³´í•˜ì—¬ ëª¨ë¸ì˜ ì¼ë°˜í™” ì„±ëŠ¥ì„ í–¥ìƒì‹œí‚¬ í•„ìš”ê°€ ìˆìŠµë‹ˆë‹¤.
*   **CTEs í•´ì„ì˜ ì–´ë ¤ì›€:** CTEsë¥¼ ì •í™•í•˜ê²Œ í•´ì„í•˜ê³ , ê° ë ˆì´ì–´ì˜ ê¸°ì—¬ë„ë¥¼ í‰ê°€í•˜ëŠ” ê³¼ì •ì´ ë³µì¡í•˜ê³  ì£¼ê´€ì ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.

### ğŸ”— ë‚´ ì—°êµ¬ì™€ì˜ ì—°ê´€ì„±
ë³¸ ë…¼ë¬¸ì˜ ì—°êµ¬ëŠ” ì œê°€ ì§„í–‰í•˜ê³  ìˆëŠ” MLLM ëª¨ë¸ ë¨¸ì§• ë° í•œêµ­ì–´ Multimodal LLM ê°œë°œ ì—°êµ¬ì™€ ë°€ì ‘í•˜ê²Œ ê´€ë ¨ë©ë‹ˆë‹¤. íŠ¹íˆ, â€˜ë ˆì´ì–´ë³„ í•™ìŠµë¥  ì¡°ì •â€™ ë°©ì‹ì€ ëª¨ë¸ì˜ íŠ¹ì • ë ˆì´ì–´ê°€ íŠ¹ì • ì‘ì—…ì— ë” ì¤‘ìš”í•œ ì—­í• ì„ í•  ìˆ˜ ìˆë‹¤ëŠ” ì ì„ ê³ ë ¤í•˜ì—¬, MLLM ëª¨ë¸ì˜ ì„±ëŠ¥ì„ ìµœì í™”í•˜ëŠ” ë° í™œìš©ë  ìˆ˜ ìˆìŠµë‹ˆë‹¤. ë˜í•œ, â€˜ì˜ë£Œ ë¶„ì•¼ íŠ¹í™” ë²¤ì¹˜ë§ˆí¬â€™ëŠ” í•œêµ­ì–´ ì˜ë£Œ ë°ì´í„°ì…‹ êµ¬ì¶• ì‹œ ì°¸ê³ í•  ìˆ˜ ìˆëŠ” ì¢‹ì€ ìë£Œê°€ ë  ìˆ˜ ìˆìœ¼ë©°, â€˜í•´ì„ ê°€ëŠ¥ì„±â€™ì— ëŒ€í•œ ê°•ì¡°ëŠ” ëª¨ë¸ì˜ ì‹ ë¢°ì„±ì„ ë†’ì´ëŠ” ë° ì¤‘ìš”í•œ ìš”ì†Œì…ë‹ˆë‹¤.

### ğŸ’¡ ì—°êµ¬ ì•„ì´ë””ì–´ ì œì•ˆ
*   **ë‹¤ì–‘í•œ ë¶„ì•¼ì— ì ìš© ê°€ëŠ¥í•œ NAST í™•ì¥:** ì˜ë£Œ ë¶„ì•¼ ì™¸ì— ë‹¤ë¥¸ ë¶„ì•¼ (ì˜ˆ: ë²•ë¥ , ê¸ˆìœµ)ì—ì„œë„ ë¶€ì •ì–´ ë¬¸ì¥ì´ ì¤‘ìš”í•œ ì—­í• ì„ í•˜ëŠ” ê²½ìš°, NAST ë°©ë²•ì„ í™•ì¥í•˜ì—¬ ì ìš©í•´ ë³¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.
*   **CTEs í•´ì„ ìë™í™”:** CTEs í•´ì„ ê³¼ì •ì„ ìë™í™”í•˜ëŠ” ê¸°ìˆ ì„ ê°œë°œí•˜ì—¬, ëª¨ë¸ì˜ ì‘ë™ ë°©ì‹ì„ ë”ìš± íš¨ìœ¨ì ìœ¼ë¡œ ë¶„ì„í•˜ê³ , ìµœì í™”ì— í™œìš©í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.
*   **í•œêµ­ì–´ ì˜ë£Œ ë°ì´í„°ì…‹ êµ¬ì¶•:** í•œêµ­ì–´ ì˜ë£Œ ë°ì´í„°ì…‹ì„ êµ¬ì¶•í•˜ì—¬, í•œêµ­ì–´ MLLM ëª¨ë¸ì˜ ì„±ëŠ¥ì„ í–¥ìƒì‹œí‚¤ê³ , ì˜ë£Œ ë¶„ì•¼ì—ì„œ MLLMì˜ í™œìš© ê°€ëŠ¥ì„±ì„ ë†’ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤. íŠ¹íˆ, ë‹¤ì–‘í•œ ë¶€ì •ì–´ í‘œí˜„ì„ í¬í•¨í•˜ëŠ” ë°ì´í„°ì…‹ êµ¬ì¶•ì— ì§‘ì¤‘í•´ì•¼ í•©ë‹ˆë‹¤.

### ğŸ“š í•µì‹¬ í‚¤ì›Œë“œ
1.  Negation Handling
2.  Layer-Specific Fine-Tuning
3.  Causal Tracing Effects (CTEs)
4.  Medical Vision-Language Models (VLM)
5.  Interpretability-Guided Optimization

---

> ğŸ¤– ì´ ê¸€ì€ AI ì—°êµ¬ ì–´ì‹œìŠ¤í„´íŠ¸ì— ì˜í•´ ìë™ ìƒì„±ë˜ì—ˆìŠµë‹ˆë‹¤.
> ë¶„ì„ ëª¨ë¸: google/gemma-3-4b-it:free
